Hemicrania Continua-Like Headache Related to Transdermal Nitroglycerine Therapy

Federico Mainardi1, Giorgio Zanchin2, Ferdinando Maggioni2

  • 1Headache Centre, Neurological Division, SS Giovanni e Paolo Hospital, Venice, Italy.

Headache
|December 10, 2016
PubMed

Insights

This study reports a rare case of hemicrania continua (HC) triggered by transdermal nitroglycerine patch (TNP) use. Discontinuation of the TNP resolved the HC-like headache, highlighting a potential medication-induced headache.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Hemicrania continua (HC) is a rare, continuous, one-sided headache disorder.
  • While several symptomatic cases of HC exist, medication-induced triggers are less commonly reported.

Observation:

  • A 66-year-old male with a history of migraine without aura developed a new headache meeting HC criteria.
  • The headache onset was directly linked to the use of a transdermal nitroglycerine patch (TNP).

Findings:

  • Discontinuation of the TNP led to prompt resolution of the HC-like headache.
  • Headache recurrence was observed upon reintroduction of nitroglycerine, confirming the causal link.
  • The patient remained headache-free at one-year follow-up after permanent TNP cessation.

Implications:

  • This case suggests that transdermal nitroglycerine patches can potentially induce hemicrania continua-like headaches.
  • Clinicians should consider medication history, including transdermal patches, in the differential diagnosis of new-onset continuous headaches.
  • Further research may be warranted to explore the mechanisms underlying nitroglycerine-induced headaches.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.8K
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
514
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
921
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K